chrisvoncsefalvay/vaers-outcomes huggingface dataset:
her upper chest, the medial aspect of her left arm and down her upper arm initially pain; her upper chest, the medial aspect of her left arm and down her upper arm initially pain/fingers ached; down her upper arm initially pain; About 15 minutes later her wrist and fingers ached/joint pain; a gradual increase of body aches; nausea; feeling 'hot'; Big time tired, fatigue the patient would go to bed early; This is a spontaneous report from a contactable Nurse (patient).  A 57-year-old female patient received first dose BNT162B2 (Pfizer BioNTech Covid 19 vaccine), via an unspecified route of administration at Arm Left on 25Jan2021 14:15 at the 57 years old at single dose for COVID-19 immunization.  The medical history included FAP (Familial adenomatous polyposis), hernia repair, ankylosing spondylitis, bipolar disorder II, chronic depression, PTSD(Post-traumatic stress disorder), anxiety, GERD, Penicillin allergy, Adhesive tape allergy, Antiemetics allergy. The concomitant medications were amlodipine, ASA, HCTZ, lamotrigine (LAMICTAL), losartan, naproxen. The patient previously took Ciprofloxacin and experienced allergy, Ativan and experienced allergy. Right after the patient received the shot on 25Jan2021 14:30, her left side of her upper chest, the medial aspect of her left arm and down her upper arm initially pain. About 15 minutes later her wrist and fingers ached. From then on 25Jan2021 14:30, a gradual increase of body aches and joint pain, some nausea feeling 'hot' but not 'hot flashes' no sweats, Big time tired, fatigue the patient would go to bed early. She was keeping very hydrated. There was no other vaccine in four weeks. There was no treatment for the adverse events. There was no covid prior vaccination. There was no covid tested post vaccination. The outcome of the events was recovering.    Information about lot/batch number has been requested.
Large edematous area increase left arm, hot, red, hard- 1st complaint of pain evening of immunization. Parent did not eval. child's complaint.
large welt appeared @ innoculation site w/in hrs; w/in 24 hrs pt felt stiff neck & chest discomfort upon inspiration; also felt joint pain & stiffness; sx & welt lasted about 3 dyas;
Pt c/o lightheadedness while walking-started half hour "or so" after shot (vacc admin approx 08:30). Pt sent to nurse office to call mom-going home with mom.
This is in follow-up report(s) previously submitted on 6/14/2007.  Initial and follow-up information has been received from a physician concerning two females who were vaccinated with their first dose only of Gardasil.  Subsequently the patients both developed fever and vomiting.  Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in this report.  Additional information will be provided if available.  In follow-up, it was reported by the physician's nurse that the patient was 12 years old and was vaccinated with her first dose of GARDASIL.  The nurse was unsure how long the fever and vomiting lasted.  Additional information has been requested.
This spontaneous report as received from a nurse refers to a patient of unknown age and gender. The patient's concurrent conditions and medical history were not reported. On 26-MAR-2015, the patient was vaccinated with improperly stored MMR II lot # J016234 and 19-DEC-2015, lot # K005110, expiration date 04-APR-2016 (therapy type, dose, route and site of administration were not reported). Concomitant medications were not reported. No adverse effects were reported. This is one of several reports received from the same reporter. Additional information has been requested.
patient presented to ED on 12/10/22  for two separate visits for afebrile seizures. patient was eventually transferred to hospital for neurology. patient was afebrile but had been dealing with a GI virus.
Excruciating joint pain that started in the left wrist and then moved to the right.  The pain lasted about 2-3 days each side. Excessive pain was caused by turning and putting any pressure on the writs lasted for about 1 day.
Within 15-minutes of their second vaccination, the patient reported shortness of breath and that their throat was closing. EMS evaluated the patient on-site. Patient was slightly hypertensive (144/78). EKG demonstrated Pacer rhythm, rate 60bpm, no ST elevation. The patient was placed on 4LPM O2 via nasal cannula. EMS administered 50mg IV Benadryl, 125mg IV Methylprednisolone/Solu-Medrol, and .5L IV Saline en-route. In the ED, the patient reported shortness of breath, difficulty breathing, tongue swelling, and throat swelling. EMS stated that they did not administer epinephrine. The patient was in stable condition without angioedema or signs of respiratory distress. The patient was discharged with a diagnosis of Allergic Reaction and prescribed a 4-day course of 40mg Prednisone BID.
Pain and swelling of injected arm  Headache and Body aches  Fever and Chills  Fatigue  S/S present for about 48 hours
On 3-25-2022, I begin to lose my peripheral vision in my left eye and it progressively got worse.  I went to a neuro opthamologist on 4-14, 2022. He ordered an MRI that was done on 5-12, 2022 and a Lumbar puncture on 5-18, 2022. The MRI showed that my sclera discs was enlarged and the lumbar puncture showed there was elevated head pressure. I was put on Diamox after he diagnosed me with Intracranial Hypertension on 5-24, 2022. I am doing ok now and will continue the medication for a few more months and be reevaluated in November, 2022.
Roughly 6 hours after flu and 4 hours after restarted simvastatin, he developed muscle cramps. Presented to clinic 2 days later with no specific exam findings, but cramps in all muscle areas of his body. Calcium was normal ( has severe hypocalcemia in the  past  after parathyroidectomy)  no microscopic hematuria,  nor myoglobinuria, but had CK337. He drank copious  fluids  that  day and cramps resolved in  about 8 hours.
Flu like symptoms; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 028L20A) for COVID-19 vaccination.     Concurrent medical conditions included Penicillin allergy and Allergy to antibiotic (Erythromycin).    On 28-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications were provided. No treatment information was provided.
2nd dose received > 35 days from 1st dose/2nd dose received beyond 35 days from 1st dose; This spontaneous case was reported by a nurse and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received > 35 days from 1st dose/2nd dose received beyond 35 days from 1st dose) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013F21A and 030M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 23-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) .5 milliliter. On 19-Nov-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to .5 milliliter. On 19-Nov-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received > 35 days from 1st dose/2nd dose received beyond 35 days from 1st dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (2nd dose received > 35 days from 1st dose/2nd dose received beyond 35 days from 1st dose) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant product use was provided. No treatment medication was provided.   This case was linked to MOD-2022-515212 (Patient Link).
pt recvd vax 22AUG95 230PM; became fussy that evening; on 23AUG95 8AM devel fever 102 R, crying cont, diarrhea, poor appetite; 23AUG95 fever 102 R, crying, APAP given recommended to see FMD:
Patient came in to receive standard flu shot but got COVID Pfizer dose instead.  Patient stated that she received the Janssen & Janssen vaccine back in March.
Pt recvd five doses of Engerix-B &/or Recombivax & titer checked SEP91 indicated borderline titer;
pt recv vax 10APR96 & on 3MAR97 pt devel chickenpox;it was also reported that a sibling recv vax 10APR96 & another sibling (WAES 97031345) devel chickenpox post vax;
Swelling, redness, warmth. Cold compress placed by patient. OTC pain medication taken by patient.
Patient states after receiving the Hepatits B vaccine she began to have a headache. She states she that around 12:00 AM on 04/04/2014 she started to have episodes of nausea & vomiting, chills, & diarrhea. She states she has not been able to eat since getting the vaccine.
Went back to the exam room at approximately 9:15, and would estimate the shot was administered about 9:45.  Afterwards I held patient and we helped her doll also get a Band-Aid.  We waited several minutes for the nurse to bring back a printed shot record.  Before she could come back we walked out of the room together.  Patient was starting to walk funny on her leg that received the shot.  She walked up to the front desk, I would estimate 15 feet.  Next she picked out a sticker and waited for me to make her a new appointment.  I could tell she was still having trouble walking on the leg with the shot.  We turned to walk out of the door and as she neared the fireplace she stumbled sideways and fell on her face, letting out a cry.  She stopped crying almost immediately as I picked her up and she went limp, blinking her eyes.  I immediately ran back to the desk and got the scheduler's attention that she was acting funny.  She led me back to an exam room where I laid patient down and she had a seizure and did not appear to have control of her arms and legs.  I saw her eyes roll and she was not responding to my voice.  The nurse came in to see what was happening and went to get Dr.   I'm pretty sure Dr. was in the room for at least part of the seizure.  First she took her blood pressure as I held her.  During this time patient was very pale.  The report from the doctor was that her blood pressure was low but pulse was good.  Dr. also ordered a blood sugar test that was given immediately.  During the test patient began to breathe rapidly and then returned to normal.  Sugar test was fine.  Patient seemed very lethargic after this ordeal and we stayed at the Dr. office for an hour.  Little by little she began to perk up and become more alert.  The office provided a snack of V8 fruit juice and dried fruit.
blood clot on her left eye; This is a spontaneous report from a contactable consumer (patient). A 25-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, expiry and lot number were not reported), via an unspecified route of administration, administered in the left arm on an unspecified date as 1st dose, single for covid-19 immunization. The patient's medical history and concomitant medications were not reported. It was reported that the patient woke up with a blood clot on her left eye on an unspecified date. Outcome of the event was unknown.   No follow up attempts are possible. Information about lot/batch number cannot be obtained.
Wrong vaccine administered; extreme chills; no energy/had very little energy; vomiting; confined to bed and only slept; eat very lightly (crackers, water, ginger ale); very tired; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), as dose 4 (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient didn't receive BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5). The patient had no relevant medical history. Concomitant medication(s) included: ROSUVASTATIN. Vaccination history included: Bnt162b2 (Dose 1, Single), for COVID-19 Immunization, reaction(s): "had no energy", "extreme chills", "could eat very lightly", "very tired", "confined to bed and only slept", "Vomiting"; Bnt162b2 (Dose 2, Single), for COVID-19 Immunization, reaction(s): "had no energy", "extreme chills", "could eat very lightly", "very tired", "confined to bed and only slept", "Vomiting"; Bnt162b2 (Dose 3, Single), for COVID-19 Immunization, reaction(s): "had no energy", "extreme chills", "could eat very lightly", "very tired", "confined to bed and only slept", "Vomiting". The following information was reported: WRONG PRODUCT ADMINISTERED (non-serious), outcome "unknown", described as "Wrong vaccine administered"; CHILLS (non-serious), outcome "unknown", described as "extreme chills"; ASTHENIA (non-serious), outcome "unknown", described as "no energy/had very little energy"; VOMITING (non-serious), outcome "unknown"; HYPERSOMNIA (non-serious), outcome "unknown", described as "confined to bed and only slept"; DECREASED APPETITE (non-serious), outcome "unknown", described as "eat very lightly (crackers, water, ginger ale)"; FATIGUE (non-serious), outcome "unknown", described as "very tired".  Additional information: About 15 hours after the shot, the patient had extreme chills for about 2 hours, starting adverse event extreme chills for about 2 hours, starting at 4 a.m. Beginning at about 9:00 vomiting began. She could not even take a sip of water without vomiting for the next 36 hours. During this time, she had no energy and was confined to bed and only slept. Beginning about 48 hours after the shot, she could eat very lightly (crackers, water, ginger ale) and still had very little energy. She was feeling more normal about 4 days after the shot, but still very tired. This was her 5th Pfizer shot, and she had the exact same reaction after all 5 doses. Patient received 55+ multivitamin as other medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. No known allergies reported.   The information on the batch/lot number for BNT162b2, BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
Within 12 to 18 hours after vaccine was given the area below the site began to redden and be painful in the skin and just below the skin. This redness continued to worsen for about 4-5 days. It was 3 inches by 5 inches. It was sore and itchy. I used triamicilone cream on it which I had at home and that reduced the reddness and itching but did not make it go away completely. It has continued to diminish slowly  but is day 18 now post vaccine administration and remains about 3 inches by 5 inches in size. It is not as sore The skin was slightly raised the first few days by is not raised now. I went in for my IVIG treatment today and was advised by the provider there to complete the VAERS report. The provider suspected the vaccine was given subcutaneously  instead of IM.
Broke out in shingles; This is a spontaneous report from a contactable consumer reported for herself . A 66-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot number was not reported (reported as CN6206, for confirmation), via an unspecified route of administration, at the age of 66 years, on 13Mar2021 as 1ST DOSE, SINGLE for covid-19 immunisation. Medical history was reported as none. The patient stated, "Not sure if this is, if you are the right person to help me, I broke out in shingles. I had my first vaccine two and a half weeks ago and let's see about 5 days ago I broke out with shingles (Mar2021). Now my concern is I am schedule to get another vaccine this Saturday and I talked to a pharmacist and she had a concern about whether or not I should get the second vaccine now or if I should push it off. Apparently she told me there is now a 42 days span of time in which I can get it instead of three weeks." The patient underwent lab tests and procedures which included investigation: unknown results on 26Mar2021 and physical examination: unknown results on 26Mar2021. Therapeutic measures were taken as a result of broke out in shingles (herpes zoster). The patient stated "I am taking, yes doctor gave me medication to retract." The outcome of the event was not recovered.  Information on the lot/batch number has been requested.
After receiving the 3rd dose of Pfizer Booster, Starting about a week later I have been experiencing debilitating Tinnitus - Ringing in my ears, I have never suffered from Tinnitus ever. And have been waiting for months, hoping it would go away, It affects me every day, affects my sleep, my concentration, affects my work and personal life!!! I have been seeking medical attention but am being told there is no cure and nothing that can be done to help with this condition. I strongly feel this is caused by the Pfizer injections that I received.
Friday 09/24/21 I woke up with sore throat, congested nose and ear on right side, Fever 101.2, chills, body aches, headache, fatigue, pain in right arm after vaccine lasted two days. Took Ibuprofen and rested.  Did not go to work. On Monday 09/27/21 started with Vice grip type headache in afternoon, pain level 10/10  (0-no pain/10 - worst pain) . Took OTC Migraine medicine , didn't help. Took  Fioricet and Sumatriptan. slept somewhat and woke up with headache pain 3/10 . Went to work on Monday. On Tuesday 09/28/21 began with severe headache again in the late afternoon after work, pain level 10/10 and all through the night and into morning. I took Ibuprofen, which didn't help. Since migraine meds didn't help much the day before I then took  oxycodone, little relief  so I took migraine meds- Fioricet and Sumatriptan, put ice to forehead and back of head and drank coffee 0430  on09/29/21. Pain subsided (2/10) enough to go to work. Still with a nagging discomfort at back of my head at 1055 09/29/21. 2-3/10
Doses administered after more than 1 dose administered to patient after more than 1 temperature excursion; dose administered to patient after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 031L20A and 031A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 14-Feb-2021 at 10:30 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 20-Mar-2021 at 9:03 AM, received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (Doses administered after more than 1 dose administered to patient after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (dose administered to patient after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Age of patient was reported as 65.30 for dose administered on 14-Feb-2021 and 65.40 for dose administered on 20-Mar-2021. No concomitant medications were reported. Batch number 031L20A administered on 14-Feb-2021 underwent temperature excursion with temperature range of 32 degrees Fahrenheit from 10:00 AM to 11:00 AM. This vial was moved to fridge on 09-Feb-2021 and beyond use date for the vial was reported as 10-Mar-2021. Product moved to clinic on 13-Jan-2021. Batch number 031A21A administered on 20-Mar-2021 underwent temperature excursion with temperature range of 34-37 degrees Fahrenheit from 09:00 AM to 10:00 AM. This vial was moved to fridge on 09-Mar-2021 and beyond use date for the vial was reported as 08-Apr-2021. Product moved to clinic on 20-Mar-2021. Vial was in cooler storage and was not in frozen storage during high-pace COVID-19 vaccination at around 2021. Vials were only punctured right before administration. Vaccines were not frozen at time of administration. It was reported that each time a vial was put into a cooler, sometimes there was a period of 1 hour or 1 hour and a half approximately, when temperature data logger registered a temperature of 34 or 35-degree Fahrenheit. Temperature recordings were taken using a traceable temperature monitor at every hour. No treatment medications were reported.   This case was linked to MOD-2022-566976 (Patient Link).
Expired Flulaval administered; This case was reported by a nurse via call center representative and described the occurrence of expired vaccine used in a 13-year-old female patient who received Flu Seasonal QIV Quebec (FluLaval Quadrivalent 2022-2023 season) (batch number 93Z32, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv quebec pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On 15th September 2022, the patient received FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device. On 15th September 2022, unknown after receiving FluLaval Quadrivalent 2022-2023 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.     This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 19-Sept-2022 Reporter's comment: The reporter consented to follow-up. The case was linked with cases US2022134437, US2022134438 and US2022134439 reported by same reporter for different patients. Additional supportive information: The patient received an expired dose of Flulaval quadrivalent, which led to expired vaccine used.; Sender's Comments:  US-GSK-US2022134437:Same reporter US-GSK-US2022134439:Same reporter US-GSK-US2022134438:Same reporter
Rash began this morning after the vaccine. Worse at injection site (left deltoid) generalized urticarial. Treated with Benadryl. Then 1D later Prednisolone by PCP.
Soreness; Swelling; Redness; This case was reported by a consumer via interactive digital media and described the occurrence of pain in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced pain, swelling and erythema. On an unknown date, the outcome of the pain, swelling and erythema were unknown.   It was unknown if the reporter considered the pain, swelling and erythema to be related to Shingles vaccine.  Additional details were provided as follows: The patient self-reported this case. The age at vaccination was not reported. The patient got the shingle shot and it was the first one to give soreness, swelling and redness. The patient also reported that it had put a big hole in his/her pocketbook. The follow-up would not possible as no contact details were available.
1FEB97 t100, productive cough;4FEB97 pt given med x 21 days;